1. Home
  2. MYO

as 09-08-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Industrial Specialties

Nasdaq

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Founded: 2004 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 44.6M IPO Year: 2017
Target Price: $8.17 AVG Volume (30 days): 2.1M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.25 EPS Growth: N/A
52 Week Low/High: $0.92 - $7.17 Next Earning Date: 11-05-2025
Revenue: $40,760,091 Revenue Growth: 93.08%
Revenue Growth (this year): 25.69% Revenue Growth (next year): 23.52%

MYO Daily Stock ML Predictions

Stock Insider Trading Activity of Myomo Inc. (MYO)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
KIRK THOMAS F MYO N/A Aug 25 '25 Buy $1.15 50,000 $57,500.00 474,420
KIRK THOMAS F MYO N/A Aug 18 '25 Buy $1.10 50,000 $55,000.00 474,420
GUDONIS PAUL R MYO Chief Executive Officer Aug 15 '25 Buy $0.95 50,000 $47,295.00 1,259,013

Share on Social Networks: